Mechanisms of distal axonal degeneration in peripheral neuropathies
CR Cashman, A Höke - Neuroscience letters, 2015 - Elsevier
Peripheral neuropathy is a common complication of a variety of diseases and treatments,
including diabetes, cancer chemotherapy, and infectious causes (HIV, hepatitis C, and …
including diabetes, cancer chemotherapy, and infectious causes (HIV, hepatitis C, and …
[HTML][HTML] Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials
TJC Phillips, CL Cherry, S Cox, SJ Marshall, ASC Rice - PloS one, 2010 - journals.plos.org
Background Significant pain from HIV-associated sensory neuropathy (HIV-SN) affects∼
40% of HIV infected individuals treated with antiretroviral therapy (ART). The prevalence of …
40% of HIV infected individuals treated with antiretroviral therapy (ART). The prevalence of …
Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations
There is emerging evidence that people with successfully treated HIV infection age
prematurely, leading to progressive multi-organ disease, but the reasons for this are not …
prematurely, leading to progressive multi-organ disease, but the reasons for this are not …
Assessment of neuropathic pain in primary care
ML Haanpää, MM Backonja, MI Bennett… - The American journal of …, 2009 - Elsevier
Management of patients presenting with chronic pain is a common problem in primary care.
Essentially, the classification of chronic pain falls into 3 broad categories:(1) pain owing to …
Essentially, the classification of chronic pain falls into 3 broad categories:(1) pain owing to …
Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study
P Vivithanaporn, G Heo, J Gamble, HB Krentz, A Hoke… - Neurology, 2010 - AAN Enterprises
Background: Combination antiretroviral therapy (cART) has improved the survival of patients
with HIV/AIDS but its impact remains uncertain on the changing prevalence and incidence of …
with HIV/AIDS but its impact remains uncertain on the changing prevalence and incidence of …
[HTML][HTML] Neurologic complications of HIV disease and their treatment
Findings on the nervous system complications of HIV disease and their impact on people
living with HIV continue to accumulate. New reports at the 17 th Conference on Retroviruses …
living with HIV continue to accumulate. New reports at the 17 th Conference on Retroviruses …
Peripheral neuropathy in HIV: prevalence and risk factors
Objectives: To estimate neuropathic sign/symptom rates with initiation of combination
antiretroviral therapy (cART) in HIV-infected ART-naive patients, and to investigate risk …
antiretroviral therapy (cART) in HIV-infected ART-naive patients, and to investigate risk …
Neurological and psychiatric adverse effects of antiretroviral drugs
MS Abers, WX Shandera, JS Kass - CNS drugs, 2014 - Springer
Antiretroviral drugs are associated with a variety of adverse effects on the central and
peripheral nervous systems. The frequency and severity of neuropsychiatric adverse events …
peripheral nervous systems. The frequency and severity of neuropsychiatric adverse events …
Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?
J Underwood, KR Robertson, A Winston - Aids, 2015 - journals.lww.com
Whilst effective antiretroviral therapy is protective against the more severe forms of HIV-
associated brain disease, there remains a large burden of clinically symptomatic cognitive …
associated brain disease, there remains a large burden of clinically symptomatic cognitive …
[HTML][HTML] HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain
Histone deacetylase inhibitors (HDACIs) interfere with the epigenetic process of histone
acetylation and are known to have analgesic properties in models of chronic inflammatory …
acetylation and are known to have analgesic properties in models of chronic inflammatory …